Kurma Partners Overview
Kurma Partners, founded in 2009 and based in Paris, France, is a prominent European venture capital firm focusing on healthcare and biotechnology sectors. The firm manages approximately €890 million in assets and has financed 72 companies since its inception. Kurma Partners invests at various stages, from company creation to capital expansion, and has founded 25 companies to date. In April 2025, Eurazeo acquired the remaining shares of Kurma Partners, integrating it fully into the Eurazeo group.
Is Kurma Partners the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Kurma Partners, along with a list of other relevant VCs, is available on Hopohopo.io.
Kurma Partners
Investment focus
Invest in
- Baltics
- Nordics
- Western Europe
- Southern Europe
- Central Eastern Europe
- North America 1 / 5
Product type
- Software
- Hardware
- Materials
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- Health Data, Healthcare Systems & Infrastructure
- MedTech & Devices
- PharmaTech
Investment role
Lead and follow
Stages
Pre-seed, Seed, Series A
First ticket size
€3,000,000 - €10,000,000
Contact information
CFO - Partner
Sylvain Cascarino
How to approach funds like Kurma Partners
Kurma Partners values founders who can articulate a clear path from scientific innovation to commercial impact, especially those with strong clinical validation or a differentiated technology platform. Highlight your team's domain expertise and your strategy for navigating regulatory milestones, as Kurma is known for hands-on support in early development and scaling. Demonstrating a robust network within the healthcare ecosystem and a realistic plan for market access will resonate with their investment style.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
